For the Inventor, By the Inventor

Enter assignee name

Alameda, CA, United States of America

Insite Vision Corporation

USPTO Granted Patents = 37

% Expired Patents = 5.4

EPO Patents = 7

Trademarks = 3

Forward Citations = 1,259

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Lyle M Bowman (33 out of 45 patents)

Santosh K Chandrasekaran (9 out of 11 patents)

Erwin C Si (8 out of 17 patents)

4. Rajesh A Patel (7 out of 10 patents)

5. James Frederick Pfeiffer (6 out of 16 patents)

6. Jon R Polansky (6 out of 19 patents)

7. John C Babcock (6 out of 6 patents)

8. Sheng-Wan Tsao (6 out of 6 patents)

9. Roy D Archibald (5 out of 5 patents)

10. Chandler R Dawson (4 out of 4 patents)

11. Stephen Pham (3 out of 20 patents)

12. Leslie A Clark (3 out of 4 patents)

13. Thomas B Ottoboni (2 out of 53 patents)

14. Tang Nguyen (2 out of 2 patents)

15. Joseph R Robinson (2 out of 28 patents)

37 patents: Sort by Forward Citations

1. 9789080 - Ophthalmic formulations of mycophenolic acid (2017-10-17),

2. 9044508 - Concentrated aqueous azalide formulations (2015-06-02),

3. 8778999 - Non-steroidal anti-inflammatory ophthalmic compositions (2014-07-15),

4. 8695850 - Tip arrangement for a dropper bottle (2014-04-15),

5. 8501800 - Controlled-release ophthalmic vehicles (2013-08-06),

6. 7795231 - Concentrated aqueous azalide formulations (2010-09-14),

7. 7749970 - Topical treatment of prevention of ocular infections (2010-07-06),

8. 7732415 - Topical treatment or prevention of ocular infections (2010-06-08),

9. D603525 - Charging fixture with valves (2009-11-03),

10. D543118 - Drop dispenser (2007-05-22),

11. 7141607 - Methods and compositions for treating and inhibiting retinal neovascularization (2006-11-28),

12. 7056893 - Topical treatment for prevention of ocular infections (2006-06-06),

13. 6569443 - Topical treatment or prevention of ocular infections (2003-05-27),

14. 6397849 - Methods of ophthalmic administration (2002-06-04),

15. 6378526 - Methods of ophthalmic administration (2002-04-30),

InSite Vision Corporation is a biopharmaceutical company specializing in developing and commercializing innovative ophthalmic products to address unmet needs in the treatment of eye diseases. With a focus on developing novel therapies for ocular infections, inflammation, and pain, InSite Vision is committed to improving patients' quality of life through its advanced eye care solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Insite Vision Corporation

37 Patents

#13 in Alameda, CA

#2,185 in California

#9,234 in US

#18,222 in the World

Alameda, CA, United States of America

Insite Vision Corporation

Forward Citations = 1,259

40 inventors:

Lyle M Bowman (33 out of 45 patents)

Santosh K Chandrasekaran (9 out of 11 patents)

Erwin C Si (8 out of 17 patents)

4. Rajesh A Patel (7 out of 10 patents)

5. James Frederick Pfeiffer (6 out of 16 patents)

Please report any incorrect information to [email protected]

Loading…